EFS Presentations at TCT 2019

TCT (Transcatheter Cardiovascular Therapeutics) is an annual scientific symposium of the Cardiovascular Research Foundation that provides an educational meeting space to discuss interventional cardiovascular medicine. This symposium provides hands-on training, interactive learning, live case demonstrations, networking opportunities, and learning from world-class faculty. Chip Hance, one of MDIC’s board members, and Andrew Farb from the FDA who works closely with MDIC, presented at the TCT 2019 meeting in San Francisco, California.

Download Materials Presented:

• Promoting Innovation Through EFS: MDIC Perspectives | Chip Hance, Board Champion
• The US EFS and Breakthrough Devices Programs FDA Update | Andrew Farb, MD Chief Medical Officer, Office of Cardiovascular Devices FDA